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Introduction
Tuberculosis (TB) control in the Russian Federation 
(RF) has a national importance. Since 1993, the Russian 
Federation is consistently implementing the federal TB con-
trol programmes, established by the regulations of the Min-
istry of Health, according to the requirements of the World 
Health Organization. Starting from 2015 a common elec-
tronic platform for case surveillance was developed and im-
plemented in the RF. It allowed the monitoring of diagnosis 
and treatment, including MDR-TB and TB/HIV co-infected 
patients. Actually the electronic platform is used in some 
regions of the RF and its national implementation depends 
on the project outcomes. The RF joined the resolution of 
the 67th session of World Health Assembly, which set up the 
goal to end tuberculosis globally by 2050. In this way the 
Russian TB control strategy outlined the following targets: 
1. Early detection of TB patients by active screening with a 
coverage of at least 70% of the population; 2. Chemopreven-
tive treatment of 100% TB/HIV coinfected individuals with 
a СD4 lymphocytes count below 350 cells/ml; 3. Total sup-
ply with the anti-tuberculosis drugs for MDR-TB including 
XDR-TB in 100% of patients; 4. Ensuring a treatment suc-
cess rate at least 75% in drug susceptible cases and 55% in 
MDR-TB cases; 5. Research, including innovative develop-
ment for improving the patient’s care; 6. Extension of the 
collaboration with the Commonwealth of the Independent 
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Abstract
Background:  The comparative assessment of the epidemiological indices and challenging issues of the tuberculosis control in the Russian Federation.
Material and methods: In the study were used the analytical annual reports of the statistical indices registered and the electronic resources of the Federal 
Research Institute for Health Organization and Informatics of the Russian Ministry of Health.
Results: The tuberculosis epidemiological situation in the Russian Federation is continuously improving. The achieved indices in disease control were 
71.3% of the population annually screened and the rate of 51.5% patients with microbiological sputum conversion from positive to negative. During the 
period from 2000 till 2017, the incidence decreased from 90.4 to 48.3 per 100 000 population, the incidence in children aged between 0 and 14 years 
old decreased from 19.1 in 2001 to 9.7 in 2017 and in children aged between 15 and 17 reduced from 40.5 (the highest level) in 2005 to 21.6 in 2017 
(the lowest level 16.6 in 1992). One of the contributing factors with an important impact on the epidemiological state represents the HIV-infection, the 
incidence of which went up from 6.5% in 2009 to 20.9% in 2017.  In 2017, the effectiveness of treatment based on bacterial conversion was reported in 
70.7% of new cases, and closure of cavitary lesions was reported in 62.9% of cases.
Conclusions: Russia made certain progress in tuberculosis control, however, the vast territory, its heterogeneity, including climatic and social economic 
differences, affect the epidemiological situation. Big efforts were performed for solving the problems associated with the infection control. The 
epidemiological data determined an increasing rate of the MDR-TB and TB/HIV co-infected patients, which required the development of the new 
approaches in tuberculosis control.
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States, countries of the Eurasian Economic Community and 
BRICS countries. 
Actually the TB control activities in the RF are consid-
ered a part of the state programme “Healthcare Develop-
ment”. The national TB control is reflected in the President’s 
decrees. According to the Decree of 07.05.2012 regarding 
“The improvement of the state policy in health care” and the 
state program “Healthcare Development for 2013-2020” the 
TB mortality should target 11.8 cases per 100 000 popula-
tion. The value was achieved in advance and in 2017 the dis-
ease mortality decreased to 6.4 per 100 000 population. The 
“Healthcare Development” program provided the reduction 
of the TB incidence to 35 per 100 000 population. In or-
der to reduce the disease mortality and incidence, the na-
tional program provided the assessment of such indicators: 
the rate of the population covered with the annual active 
screening (target value was established 70.1%) and the rate 
of patients with the sputum conversion among microscopic 
positive patients (target value 45%). The achieved indicators 
were registered in terms of 71.3% of the population actively 
screened and 51.5% of the microscopic positive patients 
converted their microscopic positive state [5].
Material and methods
In the study were used the analytical annual reports of 
the statistical indices registered in the Russian Federation 
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and the electronic resources of the Federal Research Insti-
tute for Health Organization and Informatics of the Russian 
Ministry of Health.
Results and discussion
Assessing the epidemiological indicators registered be-
tween 2000 and 2017 the incidence of TB went down by 
46.6% (from 90.4 to 48.3 per 100 000 population) and by 
7.3% in the period 2016-2017 (from 53.3 to 48.3 per 100 000 
population). The mortality due to tuberculosis decreased 
3.5 times, from 22.1 per 100 000 population in 2005 to 6.4 
per 100 000 population in 2017[1, 2, 3]. The indices were 
reflected in the figure 1.
Fig. 1.  Tuberculosis incidence and mortality during the period 
1970 and 2017.
Tuberculosis affected more men than women in the RF. 
So, in the young age groups, in the economic and reproduc-
tive period (18-44 years old) men were 61.2% of patients. 
The rate of the women aged between 25 and 34 years during 
the period 2009-2017 was in the range of 30.5-32.1% from 
the total number of patients. A decreasing tendency of the 
TB incidence in both men and women’ groups was estab-
lished. So, the TB incidence in men in the period 2009-2017 
decreased from 124.1 per 100 000 in 2009 to 70.7 per 100 
000 and in women from 46.9 per 100 000 to 28.9 per 100 
000 population.
The TB incidence registered in children aged between 0 
and 14 years old decreased by 49.2% in the period 2001-2017 
from 19.1 per 100 000 population to 9.7 per 100 000 popula-
tion. The lowest value was reported in 1992 in terms of 9.4 
per 100 000. The TB incidence in children aged between 15 
and 17 years old decreased by 46.7% during the period 2005-
2017. So, the incidence registered in 2005 declined from 40.5 
per 100 000 to 21.6 per 100 000 in 2017. However, the lowest 
value reported in 1992 of 16.6 per 100 000 was not achieved 
[1, 2, 3, 5]. Data are shown in the figure 2.
A positive evolution of the TB incidence was registered 
in both, urban and rural population of the RF. The TB in-
cidence in the rural population was higher than in the ur-
ban population and decreased during the period 2008-2017 
from 96.4 to 53.5 per 100 000 population in rural residents 
of the RF and from 80.9 per 100 000 population to 46.5 per 
100 000 population in urban residents. The proportion of 
newly diagnosed TB patients in the rural areas is almost 
one-third from all registered cases (28.4%). Data are shown 
in the figure 3.
Fig. 3.  Distribution of the epidemiological indices according to 
the demographic area of registered patients.
While distributing patients according to the regions it 
was established that the severest epidemic state of tubercu-
losis was reported in the Far East, Siberian and Ural federal 
districts. The lowest incidence and mortality indices were 
registered in the Central, North-Western and North-Cauca-
sian federal districts which were approached to the Central 
European ones[4]. Data are shown in the figure 4.
One of the emergent epidemiological problems with a 
negative impact on the TB indices in the Russian Federation 
is the rate TB/HIV co-infection in newly detected patients. 
According to the executive order of October 2016 the Rus-
sian Federation government approved the National Strategy 
to Combat the Spread of HIV-infection. Over the period 
from 2009 to 2017 the proportion of newly diagnosed TB 
patients among HIV-infection increased 3.2 times from 
Fig. 2.  Distribution of disease incidence in adults, children 0-14 
years and 15-17 years old.
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6.5% in 2009 to 20.9% in 2017. Among previously treated 
patients the associated TB/HIV co-infection increased 3.4 
times from 5.5% in 2009 to 18.5% in 2017 [6]. Indices were 
shown in the figure 5.
Fig. 5.  The rate of TB/HIV coinfection among new and 
previously treated cases.
Another problem that negatively affects the dynamics 
of the epidemiological indices in the Russian Federation is 
the increasing rate of the multidrug-resistant tuberculosis 
(MDR-TB) among new and previously treated patients. The 
MDR-TB registration started in the Russian Federation in 
1999. So, the rate of the MDR-TB among new microbiologi-
cal positive cases increased 4 times from 6.7% in 1999 to 
27.4% in 2017 and 5 times from 10.5% to 54.0% in previ-
Fig. 4.  The distribution of the epidemiological indices: incidence 
and relapse according to the Districts of the Russian Federation.
ously treated cases. Multiple causes contributed to the ris-
ing of the MDR-TB rate in the previously treated cases. The 
most important were: inadequate treatment without taking 
into consideration the drug susceptibility, low treatment 
adherence reflecting the poor patients’ supervision, lack of 
an appropriate variety and quantity of the anti-tuberculosis 
drugs[5].
During the period from 2002 till 2017 the disease preva-
lence decreased by 59.8% from 272.8 per 100 000 popula-
tion to 109.8 per 100 000 population. The rate of the severest 
form with the highest epidemiological danger fibro-cavern-
ous tuberculosis decreased 2 times from 25.0 to 10.2 per 100 
000 population during the period 2002 till 2017. The rate of 
the microscopic positive patients decreased during the pe-
riod 2002 till 2017 two times from 88.5 per 100 000 popula-
tion to 46.0 per 100 000 population. It can deduct an earlier 
screening of limited forms and increasing the use of the 
molecular genetic methods in the diagnosis of tuberculosis. 
Fig. 7. The distribution of the epidemiological indices: 
prevalence, the rate of the sputum positive cases and the rate of 
the fibro-cavitary tuberculosis.
The anti-tuberculosis treatment effectiveness reflects 
an important impact on the disease prevalence. Using a 12 
months regimen the closure of the lung cavities was achieved 
in 62.9% of new pulmonary cases, compared with 62.8% in 
2016 and the microbiological positive state converted into 
negative in 70.7% of cases in 2017, compared with 70.2% in 
2016. The closure of the lung cavities in relapsed cases using 
a 12 month regimen achieved 40.3% of cases in 2016, com-
pared with 41% in 2015 and 41.9% in 2014. Microbiological 
conversion of the positive state into negative was reported 
in 46.6% in 2016 compared with 43.5% of cases in 2009. The 
rate of the clinical cured patients increased from 28.5% in 
2005 to 35.7% of cases in 2015, 35.6% in 2016 and 38.2% 
in 2017. The rate of the patients with sputum conversion in 
culture positive patients increased from 30.8% in 2005 to 
51.5% of cases in 2017. The increased rate of the microbio-
logic conversion in the MDR-TB cases from 5.7% in 2005 to 
28.7% in 2017 was due to the allocation of funds from the 
federal budget for the procurement of the expensive anti-
tuberculosis drugs[4].
Fig. 6.  The proportion/rate of MDR-TB among new and 
previously treated cases.
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Conclusions
The Russian Federation made certain progress in tuber-
culosis control, however, the vast territory, its heterogeneity, 
including climatic and socio-economic differences, affect 
the epidemiological situation. Big efforts were performed 
for solving the problems associated with the infection con-
trol.
The epidemiological indices went down. More expressed 
was the reducing of the the mortality rate. The rate of the af-
fected men is maintaining at the same level, demonstrating 
the persistence of the social and behavioral risk factors in 
the male groups.
The epidemiological indices in the pediatric population 
went down, however the lowest level registered in 1992 was 
not achieved. The rate of tuberculosis in urban and rural 
population remains in average at the same level.
Big differences of the epidemiological indices were regis-
tered in different districts, demonstrating regional disparity 
in the social economic development and accessibility to the 
health care services.
The increasing rate of the TB/HIV infection demon-
strated the limited resources available in the control of both 
infections.
The epidemiological data determined several times in-
crease of the MDR-TB rate in primary and previously treat-
ed cases, due to multiple causes.
The decreasing rate of the fibro-cavitary tuberculosis 
and the rate of microscopic positive cases demonstrated the 
early diagnosis using the annual radiological screening and 
the molecular genetic method with substantially improved 
diagnosis sensibility.
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